1233-1235
Editorial
Something old, something new, PET in adrenal imaging
Milton D. Gross and Domenico Rubello
1236-1239
Editorial
Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?
Jean-François Chatal, Françoise Kraeber-Bodéré and Jacques Barbet
1240-1248
Original Article
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases
Amal A. El-Mabhouh and John R. Mercer
1249-1258
Original Article
Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons
M. Jules Mattes and David M. Goldenberg
1259-1271
Original Article
Open AccessClinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(l-lactic acid) microspheres in healthy pigs
M. A. D. Vente, J. F. W. Nijsen, T. C. de Wit, J. H. Seppenwoolde and G. C. Krijger, et al.
1272-1281
Original Article
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer
Michael J. Willhauck, Bibi-Rana Sharif Samani, Ingo Wolf, Reingard Senekowitsch-Schmidtke and Hans-Jürgen Stark, et al.
1282-1289
Original Article
Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism
P. Mahy, X. Geets, M. Lonneux, P. Levêque and N. Christian, et al.
1290-1298
Original article
Could 99mTc-glucarate be used to evaluate tumour necrosis?
In vitro and in vivo studies in leukaemic tumour cell line U937
Nathalie Perek, Odile Sabido, Nathalie Le Jeune, Nathalie Prevot and Jean-Michel Vergnon, et al.
1299-1304
Original Article
Staging the Axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer
R. Ruano, M. Ramos, J. R. Garcia-Talavera, E. Serrano and A. De Arriba, et al.
1305-1315
Original Article
18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: Is dual time point imaging worth the effort?
Ruoh-Fang Yen, Ke-Cheng Chen, Jang-Ming Lee, Yeun-Chung Chang and Jane Wang, et al.
1316-1322
Original Article
Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results
Laura L. Travaini, Giuseppe Trifirò, Laura Ravasi, Lorenzo Monfardini and Paolo Della Vigna, et al.
1323-1329
Original Article
The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI
G. Kong, C. Jackson, D. M. Koh, V. Lewington and B. Sharma, et al.
1330-1333
Editorial Commentary
Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use?
Habib Zaidi and Georges El Fakhri
1334-1342
Original Article
Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation
Cristina Crespo, Judith Gallego, Albert Cot, Carles Falcón and Santiago Bullich, et al.
1343-1349
Original Article
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT
Andrea Varrone, Valeria Sansone, Maria Teresa Pellecchia, Marianna Amboni and Elena Salvatore, et al.
1350-1356
Original Article
Open AccessAMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures
Erik Boot, Jan Booij, Gregor Hasler, Janneke R. Zinkstok and Lieuwe de Haan, et al.
1357-1366
Original Article
Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study
Angelo Del Sole, Francesca Clerici, Arturo Chiti, Michela Lecchi and Claudio Mariani, et al.
1367-1376
Original Article
The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism
Koen Van Laere, Ludwig Everaert, Lieven Annemans, Michel Gonce and Wim Vandenberghe, et al.
1377-1387
Review Article
ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine
Ferid Haddad, Ludovic Ferrer, Arnaud Guertin, Thomas Carlier and Nathalie Michel, et al.
1388-1391
Focus on
The power of synergy in the mediastinal staging of lung cancer
Giovanni Lucignani
1392-1393
Letter to the editor
Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases
John Koutsikos and Anastasia Leondi
1394-1395
Letter to the editor
Open AccessMultimodality treatment in hormone-refractory prostate cancer patients with bone metastases
Marnix G. E. H. Lam and Bernard A. Zonnenberg
1396
Letter to the Editor
Spent Technetium-99m generator body adapted for sterilization of radioactive preparations
A. Mushtaq
1397-1399
Letter to the Editor
Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective
Paolo Zanotti-Fregonara, Domenico Rubello and Elif Hindié
1400-1401
Letter to the Editor
The specific case of radiopharmaceuticals and GMP—activities of the Radiopharmacy Committee
C. Decristoforo, P. Elsinga, A. Faivre-Chauvet, B. Farstad and G. Meyer, et al.
1402
Image of the month
Diffuse bone marrow uptake of 99mTc (III) DMSA in Fanconi’s anemia
Sandip Basu, Ramesh Asopa and Surendra H. Moghe
1403-1404
Image of the month
18F-FDG PET/CT imaging in tendon xanthomatosis
Dae-Weung Kim, Chang-Guhn Kim, Soon-Ah Park and Young Cheon Na
1405-1412
Guidelines
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
Michael Lassmann, Heribert Hänscheid, Carlo Chiesa, Cecilia Hindorf and Glenn Flux, et al.